Targeted MRI–transrectal ultrasonography (MRI–TRUS) fusion biopsy is emerging as a powerful new technique to more accurately diagnose clinically significant prostate cancer. A recent study comparing the performance of MRI–TRUS fusion biopsy with the traditional 12-core approach found that this new approach might not be as effective as previously observed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Baco, E. et al. A randomized controlled trial to assess and compare the outcomes of two-core prostate biopsy guided by fused magnetic resonance and transrectal ultrasound images and traditional 12-core systematic biopsy. Eur. Urol. http://dx.doi.org/10.1016/j.eururo.2015.03.041.
Logan, J. K. et al. Current status of magnetic resonance imaging (MRI) and ultrasonography fusion software platforms for guidance of prostate biopsies. BJU Int. 114, 641–652 (2014).
Ukimura, O. et al. Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care. Eur. Urol. 63, 214–230 (2013).
Delongchamps, N. B. et al. Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies. J. Urol. 189, 493–499 (2013).
Watanabe, Y. et al. Detection and localization of prostate cancer with the targeted biopsy strategy based on ADC map: a prospective large-scale cohort study. J. Magn. Reson. Imaging 35, 1414–1421 (2012).
Siddiqui, M. M. et al. Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 313, 390–397 (2015).
Rastinehad, A. R. et al. Improving detection of clinically significant prostate cancer: magnetic resonance imaging/transrectal ultrasound fusion guided prostate biopsy. J. Urol. 191, 1749–1754 (2014).
Sonn, G. A. et al. Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. Eur. Urol. 65, 809–815 (2014).
Le, J. D. et al. Magnetic resonance imaging-ultrasound fusion biopsy for prediction of final prostate pathology. J. Urol. 192, 1367–1373 (2014).
Puech, P., Sufana-Iancu, A., Renard, B. & Lemaitre, L. Prostate MRI: can we do without DCE sequences in 2013? Diagn. Interv. Imaging 94, 1299–1311 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Churukanti, G., Siddiqui, M. MRI–TRUS fusion biopsy versus 12-core systematic biopsy. Nat Rev Urol 12, 369–371 (2015). https://doi.org/10.1038/nrurol.2015.143
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2015.143
